News

Fierce Pharma6h
Novo moves past GLP-1 spat with Hims & Hers, tapping telehealth company to offer discounted Wegovy
Novo Nordisk appears to be letting compounded GLP-1 bygones be bygones—at least, in one respect. | Novo Nordisk appears to be ...
Pharmaceutical Technology on MSN4d
FDA free to pursue semaglutide compounders after latest court ruling
Despite the decision being a win for Novo Nordisk, the compounded drugs sector is far too complex for this to be a final ...
Did Eli Lilly Just Say Checkmate to Novo Nordisk?
Eli Lilly and Novo Nordisk dominate the billion-dollar weight loss drug market. Lilly has announced positive trial results ...
Fake Ozempic drugs found in US drug supply, FDA warns
The FDA has issued a warning about counterfeit Ozempic medications, sharing the lot numbers and serial numbers of products ...
Novo Nordisk to phase out country’s largest insulin brand
In a move which could shake up the diabetes market, Novo Nordisk is discontinuing the country’s largest selling insulin, ...
Why Hims & Hers Health and LifeMD Are Skyrocketing Today
Shares of Hims & Hers Health (NYSE: HIMS) and LifeMD (NASDAQ: LFMD) are surging on Tuesday. Shares soared after pharma giant ...
24/7 Wall St.8d
Novo Nordisk (NYSE: NVO) Stock Price Prediction and Forecast 2025-2030 (April 2025)
With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...